Leptin oral - Oramed Pharmaceuticals

Drug Profile

Leptin oral - Oramed Pharmaceuticals

Alternative Names: Oral leptin capsule - Oramed Pharmaceuticals

Latest Information Update: 10 May 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Oramed Pharmaceuticals
  • Class Adipokines; Anorectics; Hormones
  • Mechanism of Action Leptin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Obesity; Type 1 diabetes mellitus

Most Recent Events

  • 02 May 2017 Preclinical trials in Obesity in Israel (PO) before May 2017
  • 02 May 2017 Preclinical trials in Type-1 diabetes mellitus in Israel (PO) before May 2017
  • 02 May 2017 Israel Ministry of Health approves a clinical trial application in Type-1 diabetes mellitus
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top